Stay updated on UCART19 Dose Escalation Study in B-cell ALL Clinical Trial
Sign up to get notified when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.

Latest updates to the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications section wording was updated to indicate automatic PubMed sourcing and that articles may not be about the study, and the revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check27 days agoChange DetectedRemoved the banner notice about lapse in government funding and NIH operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe updates are cosmetic UI/layout changes to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check56 days agoChange DetectedRemoved the 'Helpful Links Provided by Servier (Institut de Recherches Internationales Servier) Results Summary Lay Summary' section.SummaryDifference0.6%

- Check71 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference4%

- Check78 days agoChange DetectedThe page now emphasizes detailed lymphoma and virus-related infections (including specific Lymphoma subtypes and viral infections) and updates to revision version 3.1.0, while removing several broader or older hematology terms and the older revision (v3.0.2).SummaryDifference3%

Stay in the know with updates to UCART19 Dose Escalation Study in B-cell ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.